Optibrium - Optibrium creates elegant software solutions for small molecule design, optimisation and data analysis

Skip to the content

In the News:

Optibrium and Intellegens achieve further success in
Open Source Malaria initiative... Find out more >

Our Next Event:

Practical Applications of Deep Learning to Imputation
of Drug Discovery Data: Webinar 28 Apr more events >

Predicting pKa Using a Combination of Quantum Mechanical and Machine Learning Methods by Peter Hunt
Design of Drug-like Hepsin Inhibitors against Prostate Cancer and Kidney Stones by Vincent Blay
Practical Applications of Deep Learning to Imputation of Drug Discovery Data by Benedict Irwin

Copyright © 2020 Optibrium, Ltd. All Rights Reserved.
Optibrium™, StarDrop™, Augmented Chemistry™, Asteris™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View™ are trademarks of Optibrium Ltd. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., torch3D™ is a trademark of Cresset BioMolecular Discovery Ltd., and SeeSAR™ is a trademark of BioSolveIT GmbH.
US Patent Numbers 9,224,098 and 9,367,812

In the News:

Optibrium and Intellegens achieve further success inOpen Source Malaria initiative... Find out more >

Our Next Event:

Practical Applications of Deep Learning to Imputationof Drug Discovery Data: Webinar 28 Apr more events >

Optibrium and Intellegens achieve further success in
Open Source Malaria initiative... Find out more >

Practical Applications of Deep Learning to Imputation
of Drug Discovery Data: Webinar 28 Apr more events >